Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2521-2025Class II

MI Cancer Seek REF MSC000 UDI Code: (01)00860008613325(21)H5HJHDSXF MI Cancer Seek is a single-site assay...

Caris MPI, Inc / initiated 2025-06-17 / Open, Classified / root cause: software

CARIS LIFE SCIENCES began a recall of MI Cancer Seek REF MSC000 UDI Code: (01)00860008613325(21)H5HJHDSXF MI Cancer Seek is a single-site assay intended to provide tumor mutational profiling to be... on . FDA classified it as Class II and gives the reason as "Due to an incorrect test results provided that indicated the incorrect drug therapy recommendation". As of , the recall status on record is Open, Classified, and MDM tags the root cause as software.

Recall record

Recall number
Z-2521-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Caris MPI, Inc
Product
MI Cancer Seek REF MSC000 UDI Code: (01)00860008613325(21)H5HJHDSXF MI Cancer Seek is a single-site assay intended to provide tumor mutational profiling to be used by qualified healthcare professionals in accordance with professional oncology guidelines for cancer patients with previously diagnosed solid malignant neoplasms.
Product code
PQP Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
Reason for recall
Due to an incorrect test results provided that indicated the incorrect drug therapy recommendation
Root cause tag
software
FDA root cause
Software design
Action
On 07/14/2025, the firm emailed an "URGENT: MEDICAL DEVICE RECALL" Letter its customer that inform them that an incorrect CDx report was issued on April 14, 2025 with the wild-type KRAS/NRAS results with VECTIBIX (panitumumab) listed as a therapeutic option. The potential cause of the issue occurred due to two unanticipated events occurring in succession within the operational aspect of the report generation software processes of MI Cancer Seek. These two events in succession resulted in a failing file. Customer was provided with an amended report and instructed to: -Review the report paying careful attention to the amended CDx report with the header "MI Cancer Seek" which changes the wild-type KRAS/NRAS result Detected to wild-type KRAS/NRAS result to Not Detected and the KRAS G12C variant listed in the Other Alterations and Biomarkers Identified section towards the bottom of the page. The new CDx report also includes the banner, Findings did not yield any biomarker results with Companion Diagnostic (CDx) claims . For questions, contact Regulatory Affairs at 351-220-3883 Monday thru Friday 8:00 AM to 5:00 PM Mountain Standard Time or email [email protected]. In addition Caris Customer Support +1-888-979-8669
Quantity in commerce
1
Distribution
U.S. Nationwide distribution in the state of NY.
Product codes and lots
Catalog Number: MSC000 UDI Code: (01)00860008613325(21)H5HJHDSXF Serial Number: H5HJHDSXF

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2521-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2521-2025Class IIOngoingVoluntary: Firm initiated